Effect of Candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of Colitis ulcerosa

Journal of Physiology and Pharmacology

Volumn 60, Issue 1, 2009, Pages 107-118

  Zwolinska Wcislo, M ^a   Brzozowski, Tomasz ^a   Budak, A ^a   Kwiecien, S ^a   Sliwowski, Z ^a   Drozdowicz, D ^a   Trojanowska, D ^a   Rudnicka Sosin, L ^a   Mach, T ^a   Konturek, S J ^a   Pawlik, W W ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Candida; Colonic blood flow; Fluconazole; Probiotics; Proinflammatory cytokines; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; CYTOKINE; FLUCONAZOLE; INTERLEUKIN 1BETA; LACIDOFIL; MEBEVERINE; MESALAZINE; MYELOPEROXIDASE; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; COLON BLOOD FLOW; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE MODEL; FUNGAL COLONIZATION; FUNGAL STRAIN; HEALING; HUMAN; INFLAMMATION; INTESTINE MUCOSA; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; NONHUMAN; RAT; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; COLITIS, ULCERATIVE; COLON; DISEASE MODELS, ANIMAL; FEMALE; FLUCONAZOLE; HUMANS; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; PEROXIDASE; PROBIOTICS; RATS; RATS, WISTAR; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 65949120186     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Shanahan F. Inflammatory bowel disease: immunodiagnostics, immunotherapeutics and ecotherapeutics. Gastroenterology 2001; 120: 622-635. (Pubitemid 32171636)
2. Bengmark S. Ecological control of gastrointestinal tract. The role of probiotic flora. Gut 1998; 42: 2-7. (Pubitemid 28228378)
3. Kucharzik T, Maaser C, Lugering A et al. Recent understanding of IBD pathogenesis: implications for future therapies. Inflamm Bowel Dis 2006; 12: 1068-1083. (Pubitemid 44665477)
4. Kuhbacher T, Ott SJ, Helwig U et al. Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut 2006; 55: 833-841. (Pubitemid 43764555)
5. Linskens RK, Huijsdens XW, Savelkoul PHM, Vanderbroucke-Grauls CMJE, Meuwissen SGM. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol 2001; 12(Suppl 234): 29-40.
6. Bernhardt H, Knoke M. Mycological aspects of gastrointestinal microflora. Scand J Gastroenterol 1997; 32(Suppl 222): 102-106. (Pubitemid 27196273)
7. Cannon RD, Holmes AR, Mason AB, Monk BC. Oral Candida, clearance, colonization or candidiasis? J Dent Res 1995; 74: 1152-1161.
8. Kennedy RJ, Hoper M, Deodbar K, Kirk SJ, Gardiner KR. Probiotic therapy fails to improve gut permeability in a hapten model of colitis. Scand J Gastroenterol 2000; 12, 1266-1271.
9. Gionchetti P, Rizzello F, Venturi A. et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double- blind, placebo-controlled trial. Gastroenterology 2000; 119: 305-309. (Pubitemid 30621980)
10. Swidsinski A, Loening-Baucke V, Bengmark S, Lochs H, Dorffel Y. Azathioprine and Mesalazine-induced effects on the mucosal flora in patients with IBD colitis. Inflamm Bowel Dis 2007; 13: 51-56. (Pubitemid 46080009)
11. Muller J. Pathogen identification in indigenous deep mycoses. Basel, La Roche an Co., Co-limited Company, 1986.
12. Reuter B, Asfaha S, Buret A, Sharkey KA, Wallace JL. Exacerbation of inflammation- associated colonic injury in rat through inhibition of cyclooxygenase-2. J Clin Invest 1996; 98: 2076-2085. (Pubitemid 26376296)
13. Brzozowski T, Konturek PC, Ptak A et al. Nitric oxide releasing aspirin protects the gastric mucosa against stress and promotes healing of stress-induced gastric mucosal damage; role of heat shock protein 70. Digestion 2002; 66: 160-172. (Pubitemid 36091848)
14. Vilaseca J, Salas A, Guarner F, Rodriguez R, Malagelada JR. Participation of thromboxane and other eicosanoid synthesis in the course of experimental inflammatory colitis. Gastroenterology 1990; 98: 269-277. (Pubitemid 20037906)
15. Zwolinska-Wcislo M, Budak A, Bogdal J, Trojanowska D, Stachura J. Effect of fungal colonization of gastric mucosa on the course of gastric ulcer healing. Med Sci Monit 2001; 7: 266-275. (Pubitemid 32244808)
16. Brzozowski T, Zwolinska-Wcislo M, Konturek PC et al. Influence of gastric colonization with Candida albicans on ulcer healing in rats: effect of ranitidine, aspirin and probiotic therapy. Scand J Gastroenterol 2005; 40: 286-296. (Pubitemid 40476459)
17. Bougnoux M-E, Diogo D, Francois N et al. Multilocus sequence typing reveals intrafamilial transmission and microevolution of Candida albicans isolates from the human digestive tract. J Clin Microbiol 2006; 44: 1810-1820. (Pubitemid 43726273)
18. Mach T. Clinical usefulness of probiotics in inflammatory bowel diseases. J Physiol Pharmacol 2006; 57 (Suppl 9): 23-33. (Pubitemid 46569847)
19. Zwolinska-Wcislo M, Brzozowski T, Mach T et al. Are probiotics effective in the treatment of fungal colonization of the gastrointestinal tract? Experimental and clinical studies. J Physiol Pharmacol 2006; 57(Suppl 9): 35-49. (Pubitemid 46569848)
20. Elahi S, Pang G, Ashman R, Clancy R. Enhanced clearance of Candida albicans from the oral cavities of mice following oral administration of Lactobacillus acidophilus. Clin Exper Immun 2005; 141: 29-36. (Pubitemid 40904638)
21. Engel MA, Kellermann CA, Rau T, Burnat G, Hahn EG, Konturek PC. Ulcerative colitis in AKR mice is attenuated by intraperitoneal anandamide. J Physiol Pharmacol 2008; 59: 673-689.
22. Gackowska L, Michalkiewicz J, Krotkiewski M, Helmin- Basa A, Kubiszewska I, Dzierzanowska D. Combined effect of differential lactic acid bacteria strains on the mode of cytokines pattern expression in human peripheral blood mononuclear cells. J Physiol Pharmacol 2006; 57(Suppl 9): 13-21. (Pubitemid 46569846)
23. Heczko PB, Strus M, Kochan P. Critical evaluation of probiotic activity of lactic bacteria and their effects. J Physiol Pharmacol 2006; 57(Suppl 9): 5-12. (Pubitemid 46569845)